Robert is a Partner at Oaklins Netherlands. With almost 25 years of M&A experience, Robert has advised private owners, corporates and private equity firms on a large number of sell-side and buy-side transactions in a variety of sectors. He has a particular focus on healthcare and leads Oaklins' Healthcare Group. Key clients he has advised include Novartis, Alliance Medical, Mediq, Arseus, DSM, C.B. Fleet, Synthon, Gilde Healthcare Services, Pharmaline, Xendo and Tramedico.
Prior to joining the team in 1999, Robert was finance manager at DSM N.V., a listed multinational life sciences and performance materials company, where he was involved in the strategy to quadruple DSM's presence in fine chemicals via acquisitions. Robert has a master's in Economics from Erasmus University in Rotterdam and is a postgraduate Chartered Controller from the University of Maastricht. He is a regular guest lecturer and speaker on M&A topics.
© 2019 Oaklins. All rights reserved. Oaklins is the collective trade name of independent member firms affiliated with Oaklins International Inc. For details of the nature of affiliation, please refer to www.oaklins.com/legal.